FDA Clears Blood Test for Alzheimer’s Assessment in Primary Care
The test measures phosphorylated Tau 181 protein to help rule out Alzheimer's-related amyloid pathology in patients 55 and older.
Latest Articles
Editor's Top Picks
Can AI Learn to Smell Disease? A New Dataset Paves the Way
Researchers are developing a large-scale olfactory dataset to train artificial intelligence, potentially unlocking smell as a powerful tool for early disease detection.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
New Enzyme Aims to Break RNA Sequencing Bottleneck
A novel reverse transcriptase is designed to offer a more complete view of the transcriptome by overcoming decades-old technical hurdles in sample preparation.
Equipment & Supply Spotlight
BD, Opentrons Partner to Automate Single-Cell Multiomics Workflows
The multi-year collaboration aims to integrate robotic liquid-handling capabilities with BD single-cell instruments to accelerate disease research and drug development.
News, Know-How & Standards
Disease Detection & Understanding
New Blood-Based Assay Targets Brain-Specific Alzheimer’s Biomarker
The single-plex assay, for research use only, measures brain-derived phosphorylated tau 217 from plasma, serum, and dried blood spots without requiring cerebrospinal fluid collection.
